Aspirin resistance in patients with acute coronary syndrome. Part 2

Aspirin resistance in patients with acute coronary syndrome. Part 2

Aim. In patients with acute coronary syndrome (ACS), to investigate the prevalence of aspirin resistance, its clinical features, prognostic effects, and potential correction. Material and methods. The study included 100 ACS patients receiving aspirin. Aspirin resistance was diagnosed if at Day 7 of...

Full description

Bibliographic Details
Main Authors:	N. S. Frolova, R. M. Shakhnovich, E. M. Kaznacheeva, O. V. Sirotkina, A. B. Dobrovolskyi
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ацетилсалициловая кислота резистентность к аспирину острый коронарный синдром агрегация тромбоцитов маркеры воспаления генетические полиморфизмы
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1597

Similar Items

Aspirin resistance in patients with acute coronary syndrome. Part 1
by: N. S. Frolova, et al.
Published: (2010-12-01)

HEMOSTASIS AND FUNCTIONAL PROPERTIES OF NEUTROPHILS IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE CORONARY SYNDROME
by: I. Yu. Grinshtein, et al.
Published: (2015-10-01)

ВЫСОКАЯ ОСТАТОЧНАЯ РЕАКТИВНОСТЬ ТРОМБОЦИТОВ У ПАЦИЕНТОВ С НЕ-Q ИНФАРКТОМ МИОКАРДА
by: T. P. Pronko, et al.
Published: (2022-05-01)

ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: E. V. Gorjacheva, et al.
Published: (2016-01-01)

Antiaggregant influence on platelet aggregation in patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (2006-10-01)

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT
by: A. K. Brel, et al.
Published: (2021-08-01)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
by: A. A. Lomonosova, et al.
Published: (2015-12-01)

Acute coronary syndrome in young patients: clinical features and risk factors
by: I. V. Ponomarenko, et al.
Published: (2018-12-01)

New perspectives in immunological diagnostics of coronary heart disease
by: S. I. Davydov, et al.
Published: (2012-02-01)

ДВОЙНАЯ АНТИТРОМБОЦИТАРНАЯ ТЕРАПИЯ: НЕОБХОДИМОСТЬ ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ И ВОЗМОЖНОСТИ ЕЕ ПОВЫШЕНИЯ
Published: (2014-12-01)

Stress Induced Platelet Dysfunction in Rats with Folic Acid-Deficient Hyperhomocysteinemia
by: S. V. Alisievitch, et al.
Published: (2006-12-01)

АНТИТРОМБОТИЧЕСКАЯ ТЕРАПИЯ ПОСЛЕ ОСТРОГО КОРОНАРНОГО СИНДРОМА: ЧТО МЫ ЗНАЕМ О ВОЗМОЖНОСТЯХ ИНДИВИДУАЛИЗАЦИИ
Published: (2016-12-01)

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
by: N. F. Putchinyan, et al.
Published: (2015-12-01)

Anti-aggregant therapy in patients with coronary heart disease and gastric ulcer
by: A. B. Sumarokov, et al.
Published: (2010-10-01)

The role of clopidogrel in the current treatment of acute coronary syndrome
by: I. S. Yavelov
Published: (2020-06-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
by: S. R. Willoughby, et al.
Published: (2015-12-01)

Clopidogrel effectiveness in patients with ST elevation myocardial infarction
by: O. V. Sirotkina, et al.
Published: (2009-02-01)

EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?
by: Roman M. Shakhnovich
Published: (2018-12-01)

Zyllt in coronary atherosclerosis patients after coronary artery bypass graft surgery. Preliminary results of an open, randomized, comparative ZEUS Study
by: Y. I. Grinstein, et al.
Published: (2008-12-01)

Antiplatelet drug resistance in patients with coronary heart disease
by: V. A. Sulimov, et al.
Published: (2012-12-01)

HEMOSTASIS STATE IN PATIENTS WITH DIFFERENT SENSITIVITY TO ACETYLSALICYLIC ACID IN ISCHEMIC HEART DISEASE
by: Maxim Dmitrievich Goncharov, et al.
Published: (2019-07-01)

EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME
by: A. V. Rudakova, et al.
Published: (2015-09-01)

The rolle of carbohydrate component of neutrophil membrane glycoprotein receptors for change of its functional activity at patients with acute coronari syndroms and its combination with diabetes mellitus type 2
by: V. F. Kiritchuk, et al.
Published: (2002-06-01)

GENDER FEATURES OF INTERACTION HORMONAL ACTIVITY ADIPOSE TISSUE AND PROINFLAMMATORY STATUS IN HYPERTENSION WITH METABOLIC SYNDROME
by: I. D. Bespalova, et al.
Published: (2014-10-01)

Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01)

Prospective study one-year clinical outcomes of the Calypso coronary stent in patients presenting with acute coronary syndrome
by: В. Л. Воробьев, et al.
Published: (2017-04-01)

ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE?
by: S. A. Boldueva, et al.
Published: (2015-12-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Phospholipid metabolism and effectiveness of a glycoprotein IIb/IIIa receptor blocker tirofiban in patients with acute coronary syndrome without ST segment elevation
by: Sh. I. Makhamatova, et al.
Published: (2009-12-01)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

Platelet activation and red blood cell changes in thrombotic and rheological disturbances among coronary heart disease patients
by: T. E. Shirokova, et al.
Published: (2007-10-01)

THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY
by: O. V. Reshetko, et al.
Published: (2016-01-01)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

Coronary Arterial Stenting in Acute Coronary Syndrome
by: S. O. Sokolova, et al.
Published: (2006-02-01)

PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)